Encompass Health Corporation (EHC)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Trading at $97.74, Encompass Health Corporation (EHC) is a Healthcare company valued at 10B. Rated 46/100 (cautious) on growth potential, financial health, and momentum.
Last analyzed: 2026年2月8日Encompass Health Corporation (EHC) Healthcare & Pipeline Overview
Encompass Health delivers comprehensive post-acute care through inpatient rehabilitation and home-based services, capitalizing on the growing demand for specialized recovery and hospice care with a strong presence across 42 states and Puerto Rico, offering investors a stable healthcare play.
Investment Thesis
Encompass Health presents a notable research candidate within the growing post-acute care market. The company's dual focus on inpatient rehabilitation and home-based services positions it to capitalize on the increasing demand for specialized recovery and hospice care. With a market capitalization of $10.60 billion and a P/E ratio of 18.65, Encompass Health demonstrates financial stability and growth potential. A key value driver is the company's ability to expand its network of hospitals and home health locations, enhancing its market reach and service capabilities. The company's consistent profitability, reflected in a 9.5% profit margin and a 45.4% gross margin, further supports its investment appeal. The dividend yield of 0.68% provides a steady income stream for investors. Upcoming catalysts include continued expansion into underserved markets and potential acquisitions to bolster its service offerings.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $10.60B indicates a strong market valuation and investor confidence.
- P/E ratio of 18.65 suggests a reasonable valuation relative to earnings.
- Profit Margin of 9.5% demonstrates efficient operations and profitability.
- Gross Margin of 45.4% reflects a healthy pricing strategy and cost management.
- Dividend Yield of 0.68% provides a steady income stream for investors.
Competitors & Peers
Strengths
- Diversified service offerings in inpatient rehabilitation and home health.
- Extensive geographic footprint across 42 states and Puerto Rico.
- Strong brand reputation and established market presence.
- Experienced management team and skilled workforce.
Weaknesses
- Exposure to regulatory changes and reimbursement pressures.
- Dependence on Medicare and Medicaid payments.
- Competition from other post-acute care providers.
- Potential for operational inefficiencies and cost overruns.
Catalysts
- Continued expansion of home health and hospice services into new geographic markets.
- Strategic acquisitions of smaller regional providers to increase market share.
- Development and implementation of specialized programs for specific patient populations.
- Integration of telehealth and remote monitoring technologies to improve patient outcomes.
- Partnerships with hospitals and healthcare systems to create referral networks.
Risks
- Changes in Medicare and Medicaid reimbursement rates could negatively impact revenue.
- Increased competition from other post-acute care providers could erode market share.
- Economic downturn could reduce patient demand for elective rehabilitation services.
- Regulatory scrutiny and compliance requirements could increase operating costs.
- Litigation and liability claims could result in significant financial losses.
Growth Opportunities
- Expansion of Home Health and Hospice Services: Encompass Health has a significant opportunity to expand its home health and hospice services, particularly in regions with a growing elderly population. The market for home healthcare is projected to reach $300 billion by 2028, driven by the increasing preference for in-home care among seniors. By increasing its geographic footprint and service offerings in this segment, Encompass Health can capture a larger share of this expanding market, enhancing revenue and profitability. This expansion can be achieved through strategic acquisitions and organic growth initiatives.
- Strategic Acquisitions: Encompass Health can pursue strategic acquisitions to expand its market presence and service capabilities. Acquiring smaller regional providers of inpatient rehabilitation and home health services can provide immediate access to new markets and customer bases. These acquisitions can also bring in specialized expertise and technologies, enhancing the company's competitive advantage. The timeline for these acquisitions would be ongoing, with a focus on identifying and integrating suitable targets over the next 3-5 years.
- Technological Integration: Investing in advanced technologies, such as telehealth and remote monitoring, can improve patient outcomes and reduce costs. Telehealth solutions can enable Encompass Health to provide remote consultations and monitoring, expanding access to care for patients in rural or underserved areas. Remote monitoring devices can track patient vital signs and activity levels, allowing for early detection of potential health issues. The market for telehealth is expected to grow to $50 billion by 2027, presenting a significant opportunity for Encompass Health to enhance its service offerings and improve operational efficiency.
- Partnerships with Healthcare Systems: Collaborating with hospitals and healthcare systems can create referral networks and improve patient access to post-acute care services. By partnering with these organizations, Encompass Health can ensure a steady stream of patients requiring rehabilitation and home healthcare services. These partnerships can also facilitate the integration of care across the continuum, improving patient outcomes and reducing readmission rates. The timeline for establishing these partnerships would be ongoing, with a focus on building relationships with key healthcare providers in each market.
- Focus on Specialized Programs: Developing specialized programs for specific patient populations, such as those recovering from stroke or cardiac events, can attract more patients and enhance the company's reputation. These programs can be tailored to meet the unique needs of each patient group, providing comprehensive and coordinated care. By focusing on these specialized programs, Encompass Health can differentiate itself from competitors and become a preferred provider for patients requiring specialized post-acute care. The timeline for developing and implementing these programs would be 1-2 years, with ongoing evaluation and refinement.
Opportunities
- Expansion into underserved markets.
- Strategic acquisitions to increase market share.
- Development of specialized programs for specific patient populations.
- Integration of technology to improve patient outcomes and reduce costs.
Threats
- Changes in healthcare regulations and reimbursement policies.
- Increased competition from other post-acute care providers.
- Economic downturn affecting patient demand for services.
- Potential for litigation and liability claims.
Competitive Advantages
- Extensive network of hospitals and home health locations.
- Strong reputation for providing high-quality post-acute care.
- Established relationships with referral sources.
- Expertise in managing complex medical conditions.
- Economies of scale in operations.
About EHC
Encompass Health Corporation, founded in 1983 and headquartered in Birmingham, Alabama, is a prominent provider of post-acute healthcare services in the United States. Originally established as HealthSouth Corporation, the company rebranded to Encompass Health in January 2018, marking a strategic shift to better reflect its comprehensive service offerings. The company operates through two primary segments: Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment offers specialized rehabilitative treatment to patients recovering from conditions such as stroke, neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. These services are provided on both an inpatient and outpatient basis. The Home Health and Hospice segment delivers home health and hospice services, primarily in the Southeast and Texas. Home health services include skilled nursing, medical social work, home health aide services, and physical, occupational, and speech therapy. Hospice services provide in-home care to terminally ill patients and their families. As of June 1, 2022, Encompass Health operated 149 hospitals, 252 home health locations, and 99 hospice locations across 42 states and Puerto Rico, demonstrating a significant geographic footprint and extensive service network.
What They Do
- Operates inpatient rehabilitation facilities.
- Provides home health services including skilled nursing and therapy.
- Offers hospice care for terminally ill patients.
- Treats patients recovering from stroke and neurological disorders.
- Provides care for patients with cardiac and pulmonary conditions.
- Offers rehabilitation for brain and spinal cord injuries.
- Provides specialized care for complex orthopedic conditions and amputations.
Business Model
- Generates revenue through inpatient rehabilitation services.
- Earns revenue from home health and hospice services.
- Receives payments from Medicare, Medicaid, and private insurance.
- Focuses on providing high-quality, cost-effective post-acute care.
Industry Context
Encompass Health operates within the expanding post-acute care industry, driven by an aging population and increasing prevalence of chronic diseases. The market is characterized by a growing demand for rehabilitation and home healthcare services. The competitive landscape includes other major players such as CHE and DVA, as well as regional and local providers. Encompass Health's extensive network of facilities and comprehensive service offerings position it as a leading provider in this fragmented market. The industry is also influenced by regulatory changes and reimbursement policies, which can impact profitability and growth strategies.
Key Customers
- Patients recovering from acute illnesses or injuries.
- Individuals requiring rehabilitation services.
- Terminally ill patients and their families.
- Hospitals and healthcare systems seeking post-acute care partners.
Financials
Chart & Info
Encompass Health Corporation (EHC) stock price: $97.74 (-1.08, -1.09%)
Latest News
-
Encompass Health Expands in Delaware With New 40-Bed Unit Plans
zacks.com · 2026年3月19日
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Encompass Health Corporation - EHC
prnewswire.com · 2026年3月19日
-
Encompass Health Expands Delaware Presence with New Rehabilitation Hospital
MT Newswires · 2026年3月18日
-
Encompass Health announces plans to build a 40-bed inpatient rehabilitation hospital in Bear, Delaware
prnewswire.com · 2026年3月18日
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for EHC.
Price Targets
Consensus target: $153.00
MoonshotScore
What does this score mean?
The MoonshotScore rates EHC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
Encompass Health Expands in Delaware With New 40-Bed Unit Plans
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Encompass Health Corporation - EHC
Encompass Health Expands Delaware Presence with New Rehabilitation Hospital
Encompass Health announces plans to build a 40-bed inpatient rehabilitation hospital in Bear, Delaware
Common Questions About EHC
What are the key factors to evaluate for EHC?
Encompass Health Corporation (EHC) currently holds an AI score of 46/100, indicating low score. The stock trades at a P/E of 17.3x, below the S&P 500 average (~20-25x), potentially signaling value. Analysts target $153.00 (+57% from $97.74). Key strength: Diversified service offerings in inpatient rehabilitation and home health. Primary risk to monitor: Changes in Medicare and Medicaid reimbursement rates could negatively impact revenue. This is not financial advice.
How frequently does EHC data refresh on this page?
EHC prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven EHC's recent stock price performance?
Recent price movement in Encompass Health Corporation (EHC) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $153.00 implies 57% upside from here. Notable catalyst: Diversified service offerings in inpatient rehabilitation and home health. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider EHC overvalued or undervalued right now?
Determining whether Encompass Health Corporation (EHC) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 17.3. Analysts target $153.00 (+57% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying EHC?
Before investing in Encompass Health Corporation (EHC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding EHC to a portfolio?
Potential reasons to consider Encompass Health Corporation (EHC) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Diversified service offerings in inpatient rehabilitation and home health. Additionally: Extensive geographic footprint across 42 states and Puerto Rico. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of EHC?
Yes, most major brokerages offer fractional shares of Encompass Health Corporation (EHC) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track EHC's earnings and financial reports?
Encompass Health Corporation (EHC) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for EHC earnings announcements is recommended.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Investment decisions should be based on individual risk tolerance and financial circumstances.